The RIQAS Anti-Mullerian Hormone (AMH) Programme will be run at a frequency of 1 sample per month. The samples will be in a lyophilised format.

• Lyophilised material for enhanced stability
• Submit results and view reports online via RIQAS.Net
• High quality reliable controls – Randox has 30 plus years’ experience as a global manufacturer of QC controls
• Worlds largest EQA scheme ensuring peer groups are maximised
• Monthly reporting to reduce the risk of errors
• Cycle Starts – January 2025

What is AMH used for?

AMH is made in the reproductive tissues of both males and females. The role of AMH and whether levels are normal depend on age and gender.

An AMH test is often used to check a woman’s ability to produce eggs that can be fertilized for pregnancy. A woman’s ovaries can make thousands of eggs during her childbearing years. the number declines as a woman gets older. AMH levels help show how many potential egg cells a woman has left. This is known as the ovarian reserve. 

If a woman’s ovarian reserve is high, she may have a better chance of getting pregnant. She may also be able to wait months or years before trying to get pregnant. If the ovarian reserve is low, it may mean a woman will have trouble getting pregnant and show not delay very long before trying to have a baby.

AMH tests may also be used to:

• Predict the start of menopause, a time in a woman’s life when her menstrual periods have stopped, and she can’t
become pregnant anymore. It usually starts when a woman is around 50 years old.
• Find out the reason for early menopause
• Help find out the reason for amenorrhea, the lack of menstruation. It is most often diagnosed in girls who haven’t started
menstruating by the age of 15 and in women who have missed several periods.
• Help diagnose polycystic ovary syndrome (PCOS), a hormonal disorder that is a common cause of female infertility, the
inability to get pregnant
• Check infants with genitals that are not clearly identified as male or female
• Monitor women who have certain types of ovarian cancer

The RIQAS Microbiology Programme includes the identification of micro-organisms to Gram positive/negative, Genus and Species levels, together with Antimicrobial Susceptibility Testing according to chosen Guidelines.

Available in a bi-monthly format with 3 samples distributed twice per year.  Each strain is presented in a lyophilised pellet form within a self-contained tube containing a pre-filled ampoule for reconstitution, therefore helping to avoid cross contamination.

• Lyophilised for enhanced stability
• Multiple registrations allow for comparison between lab staff
• Possible to be used as a training tool for new and current staff
• Samples are manufactured to the highest quality
• Bi-monthly reporting
• Submit results and view reports online via RIQAS.Net
• Cycle Starts – July 2025

The RIQAS Serum Indices EQA programme is designed for the pre-analytical assessment of Haemolytic, Icteric and Lipemic (HIL) interferences.

Available in a bi-monthly format with the option to report either quantitative or semi-quantitative results for the HIL parameters, this programme also provides an assessment on how these interferences impact on up to 25 routine chemistry parameters. This provides invaluable information on whether a correct judgement is being made to report results.

• Lyophilised for enhanced stability
• Human based serum ensuring commutable sample matrix
• Bi-monthly reporting
• HIL parameters include the option of quantitative or semi-quantitative reporting
• Interpretation of chemistry parameter results
• Submit results and view reports online via RIQAS.Net
• Cycle Starts – October 2025

NOTE: If you require additional Serum Indices EQA material, you can purchase RQ9194/A. This is an additional pack containing 9 x 1ml vials to be used as a supplement to your main RQ9194 Serum Indices programme.

The RIQAS Lipid EQA programme is designed to monitor the performance of up to 7 lipid parameters. Two flexible and cost effective programme options are available.

• Accredited to ISO/IEC 17043
• Lyophilised for enhanced stability
• 100% human serum
• Bi-weekly reporting
• Choose from 3 or all 7 parameter options
• Submit results and view reports online via RIQAS.Net
• Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
• Cycles Start – January/July 2025